Plasma total homocysteine levels in patients with early-onset coronary heart disease and a low cardiovascular risk profile

Metabolism: Clinical and Experimental

Volumn 47, Issue 3, 1998, Pages 273-279

  Donner, Markus G ^a   Klein, Gernot K ^b   Mathes, Peter B ^b   Schwandt, Peter ^b   Richter, Werner O ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CYSTEINE; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; HOMOCYSTINURIA; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; RISK FACTOR; THROMBOEMBOLISM;

EID: 0031909758     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(98)90256-6     Document Type: Article

References (49)

1. Carson NAJ, Neill DW: Metabolic abnormalities detected in a survey of mentally backward individuals in Northern Ireland. Arch Dis Child 37:505-513, 1962
2. Mudd SH, Levy HL, Skovby F: Disorders of transsulfuration, in Scriver C, Beadet A, Sly W, et al (eds): The Metabolic Basis of Inherited Disease. New York, NY, McGraw-Hill, 1995, pp 1279-1327
3. Mudd SH, Finkelstein JD, Irrevere F, et al: Homocystinuria: An enzymatic defect. Science 143:1443-1444, 1964
4. Perry TL, Hansen S, MacDougall L, et al: Sulfur-containing amino acids in the plasma and urine of homocystinurics. Clin Chim Acta 15:409-420, 1967
5. Schimke RN, McKusick VA, Huang T, et al: Homocystinuria: Studies of 20 families with 38 affected members. JAMA 193:711-719, 1965
6. McCully K: Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis. Am J Pathol 56:111-128, 1969
7. Mudd SH, Skovby F, Levy HL, et al: The natural history of homocystinuria due to cystathionine β-synthase deficiency. Am J Hum Genet 37:1-31, 1985
8. 6: Relationship to atherosclerosis. J Nutr 113:2122-2133, 1983
9. Harker LH, Slichter SJ, Scott CR, et al: Homocysteinemia: Vascular injury and arterial thrombosis. N Engl J Med 291:537-543, 1974
10. Rodgers GM, Kane WH: Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. J Clin Invest 77:1909-1916, 1985
11. McDonald L, Bray C, Field C, et al: Homocysteinuria, thrombosis, and the blood platelets. Lancet 1:745-746, 1964
12. Harpel PC, Chang WT, Borth W: Homocysteine enhances binding of lipoprotein (a) to plasmin-modified fibrin providing a potential link between thrombosis and atherogenesis. Blood 76:510-515, 1990
13. Heinecke JW, Rosen H, Suzuki LA, et al: The role of sulfurcontaining amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J Biol Chem 262:10098-10103, 1987
14. Refsum H, Heiland S, Ueland PM: Radioenzymatic determination of homocysteine in plasma and urine. Clin Chem 31:624-628, 1985
15. 12 deficiency than in heterozygosity for homocystinuria due to cystathionine β-synthase deficiency. Metabolism 37:175-178, 1988
16. 6 deficiency: A model for the study of cystathionine β-synthase deficiency. J Nutr 112:1264-1272, 1982
17. Kang SS, Wong PWK, Norusis M: Homocysteinemia due to folate deficiency. Metabolism 63:458-462, 1987
18. Soria C, Chadefaux B, Coude M, et al: Concentrations of total homocysteine in plasma in chronic renal failure. Clin Chem 36:2137-2138, 1990
19. Wilcken DEL, Wilcken B: The pathogenesis of coronary artery disease: A possible role for methionine metabolism. J Clin Invest 57:1079-1082, 1976
20. Kang SS, Wong PWK, Cook HY, et al: Protein-bound homocysteine: A possible risk factor for coronary artery disease. J Clin Invest 77:1482-1486, 1986
21. Israelsson B, Brattström LE, Hultberg BL: Homocysteine and myocardial infarction. Atherosclerosis 71:227-233, 1988
22. Clarke R, Daly L, Robinson K, et al: Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med 324:1149-1155, 1991
23. Stampfer MJ, Malinow MR, Willett WC, et al: A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. JAMA 268:877-881, 1992
24. Genest JJ, McNamara JR, Upson B, et al: Plasma homocyst(e-)ine levels in men with premature coronary heart disease. J Am Coll Cardiol 16:1114-1119, 1990
25. Ubbink JB, Vermaak WHJ, Bennett JM, et al: The prevalence of homocysteinemia and hypercholesterolemia in angiographically defined coronary heart disease. Klin Wochenschr 69:527-534, 1991
26. Murphy-Chutorian D, Alderman EL: The case that hyperhomocysteinemia is a risk factor for coronary artery disease. Am J Cardiol 73:705-707, 1994
27. Robinson K, Mayer EL, Miller DP, et al: Hyperhomocysteinemia and low pyridoxal phosphate: Common and independent reversible risk factors for coronary artery disease. Circulation 92:2825-2830, 1995
28. Hopkins PN, Wu LL, Hunt SC, et al: Higher plasma homocyst(e-)ine and increased susceptibility to adverse effects of low folate in early familial coronary artery disease. Arterioscler Thromb Vasc Biol 15:1314-1320, 1995
29. 6, pyridoxal phosphate, and folate. Am J Cardiol 75:1107-1111, 1995
30. Arnesen E, Refsum H, Bonaa KH, et al: Serum total homocysteine and coronary heart disease. Int J Epidemiol 24:704-709, 1995
31. Wilcken DEL, Reddy SG, Gupta VJ: Homocysteinemia, ischemic heart disease, and the carrier state for homocystinuria. Metabolism 32:363-370, 1983
32. Boers GHJ, Smals AGH, Trijbels FJM, et al: Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 313:709-715, 1985
33. Alfthan G, Pekkanen J, Jauhiainen M, et al: Relations of serum homocysteine and lipoprotein (a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis 106:9-19, 1994
34. Nygard O, Vollset SE, Refsum H, et al: Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 274:1526-1533, 1995
35. Araki A, Sako Y, Fukushima Y, et al: Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and hypertensive subjects. Atherosclerosis 79:129-146, 1989
36. Tateishi N, Higashi T, Shinya S, et al: Studies on the regulation of glutathione level in the rat liver. J Biochem 75:93-103, 1974
37. Gotoh N, Graham A, Niki E, et al: Inhibition of glutathione synthesis increases the toxicity of oxidized low-density lipoprotein to human monocytes and macrophages. Biochem J 296:151-154, 1993
38. Araki A, Sako Y: Determination of free and total homocysteine in human plasma by high performance liquid chromatography with fluorescence detection. J Chromatogr 422:43-52, 1987
39. Malinow MR, Sexton G, Averbuch M, et al: Homocysteinemia in daily practice: Levels in coronary artery disease. Coron Artery Dis 1:215-220, 1990
40. Glueck CJ, Shaw P, Lang JE, et al: Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients. Am J Cardiol 75:132-136, 1995
41. von Eckhardtstein A, Malinow MR, Upson B, et al: Effects of age, lipoproteins, and hemostatic parameters on the role of homocysteinemia as a cardiovascular risk factor in men. Arterioscler Thromb 14:460-464, 1994
42. Malinow MR, Levenson J, Giral P, et al: Role of blood pressure, uric acid, and hemorrheological parameters on plasma homocyst(e)ine concentration. Atherosclerosis 114:175-183, 1995
43. Hultberg B, Agardh E, Andersson A, et al: Increased levels of plasma homocysteine are associated with nephropathy, but not severe retinopathy, in type I diabetes mellitus. Scan J Clin Lab Invest 51:277-282, 1991
44. Genest JJ, McNamara JR, Upson B, et al: Prevalence of familial hyperhomocysteinemia in men with premature coronary artery disease. Arterioscler Thromb 11:1129-1136, 1991
45. Stampfer MJ, Sacks M, Salvini S, et al: A prospective study of cholesterol, apolipoproteins and the risk of myocardial infarction. N Engl J Med 325:373-381, 1991
46. Castelli WP, Doyle JT, Gordon T, et al: HDL cholesterol and other lipids in coronary artery disease. Circulation 55:767-772, 1977
47. Assmann G, Schulte H: Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Am J Cardiol 70:733-737, 1992
48. Lapidus L, Bengtsson C, Larsson B, et al: Distribution of adipose tissue and risk of cardiovascular disease and death: A 12 year follow up of participants in the population study of women in Gothenburg, Sweden. BMJ 289:1257-1261, 1984
49. Peiris NP, Sothmann MS, Hoffmann RG, et al: Adiposity, fat distribution and cardiovascular risk. Ann Intern Med 110:867-872, 1989